via pharmatimes.com
By LYNNE TAYLOR
Health systems around the world are increasingly negotiating secret price rebates from pharmaceutical companies, and Canada risks losing out on these deals, new research warns.
For the study, which is published in the April issue of the journal Health Affairs, researchers interviewed policymakers from nine developed countries and analysed practices for securing confidential rebates from pharmaceutical manufacturers.
1 comment:
Why is the file must on the secret??
Post a Comment